2FIRSTS US FDA Rejects Imperial Tobacco's blu 2.4% E Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks FDA Issues MDOs to Fontem US's myblu ENDS Products 2FIRSTS US FDA Rejects Imperial Tobacco's blu 2.4% E Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks FDA Rejects Marketing Application For Blu Tobacco Flavored Disposable Vape Luckeevape China Vape Factory, Top Disposable Vape Manufacturer